William Alan Bauman MD

Clinical Trials

• Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury. Start of enrollment: 2001 Jul 01

  Completed

  Not Applicable

• Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study. Start of enrollment: 2006 Oct 30

  Withdrawn

  Phase 2

• Cardiovascular Disease Study Start of enrollment: 2007 Mar 01

  Completed

• Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury Start of enrollment: 2011 Aug 01

  Unknown status

  Phase 1

• Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI Start of enrollment: 2011 Aug 01

  Unknown status

  Phase 1

• Measurement of Autonomic Cardiovascular Integrity in Persons With SCI Start of enrollment: 2012 Jul 01

  Completed

• Denosumab Administration After Spinal Cord Injury Start of enrollment: 2015 Jan 01

  Recruiting

  Phase 4

• Coronary Artery Calcification Score and Risk Factors for Coronary Artery Disease in Persons With Spinal Cord Injury Start of enrollment: 2013 Oct 01

  Completed

• IR and Microvascular Blood Flow in SCI Start of enrollment: 2012 Dec 01

  Completed

  Not Applicable

• Zoledronic Acid Administration in Acute Spinal Cord Injury Start of enrollment: 2006 May 01

  Completed

  Phase 4

• Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI Start of enrollment: 2012 Jan 01

  Completed

  Phase 1, Phase 2

• Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury Start of enrollment: 2013 Jul 01

  Completed

• Subcutaneous Injection and Ultrasonic Dispersion of Cefazolin Into Chronic Pelvic-Region Pressure Ulcers in Persons With Spinal Cord Injury Start of enrollment: 2017 Jan 01

  Completed

  Not Applicable

• Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury Start of enrollment: 2018 Jun 01

  COMPLETED

  PHASE4

  Roles: Contact

• Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI Start of enrollment: 2021 Mar 01

  Recruiting

  Phase 4

  Roles: Principal Investigator, Contact

• Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI Start of enrollment: 2021 Nov 01

  Active, not recruiting

  Phase 4

  Roles: Principal Investigator, Contact

• Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI Start of enrollment: 2021 Mar 01

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury Start of enrollment: 2017 Apr 01

  Terminated

  Phase 4

  Roles: Contact, Principal Investigator

• Join now to see all